Buprenorphine/naloxoneNeonatal abstinence syndrome following in utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1520卷 / 1期

关键词：

D O I：

10.1007/s40278-014-3636-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：49 / 49

相关论文

共 50 条

[31] IbuprofenGoldenhar syndrome following in utero exposure: case report
Reactions Weekly, 2021, 1875 (1) : 163 - 163
[32] MisoprostolMobius syndrome following in utero exposure: case report
Reactions Weekly, 2015, 1565 (1) : 181 - 181
[33] MethadoneCategory II foetal heart rate and neonatal abstinence syndrome following in-utero exposure: case report
Reactions Weekly, 2022, 1905 (1) : 296 - 296
[34] Tianeptine abuseDependence leading to withdrawal symptoms, as well as neonatal abstinence syndrome following in utero exposure: case report
Reactions Weekly, 2016, 1585 (1) : 248 - 248
[35] WarfarinFoetal warfarin syndrome following in utero exposure: case report
Reactions Weekly, 2024, 2032 (1) : 445 - 445
[36] MetamfetamineVACTERL syndrome following in-utero exposure: case report
Reactions Weekly, 2023, 1945 (1) : 315 - 315
[37] PhenytoinFetal hydantoin syndrome following in utero exposure: case report
Reactions Weekly, 2010, 1292 (1) : 30 - 30
[38] FentanylAbstinence syndrome in a neonate following in utero exposure: case report
Reactions Weekly, 2000, 800 (1) : 8 - 8
[39] PhenytoinFetal hydantoin syndrome following in utero exposure: case report
Reactions Weekly, 2018, 1696 (1) : 308 - 308
[40] MisoprostolMöbius syndrome following in utero exposure: case report
Reactions Weekly, 2011, 1365 (1) : 32 - 32

← 1 2 3 4 5 →